ZyVersa Therapeutics, Inc. [ZVSAW] has reported $0.0 in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $75,018.0 .
Based in Somerville, New Jersey, ZyVersa Therapeutics, Inc. operates in the Manufacturing sector.